{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T18:27:04Z","timestamp":1777314424031,"version":"3.51.4"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1009132","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000}}],"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["T32HG008345"],"award-info":[{"award-number":["T32HG008345"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014576","name":"Office of the President, University of California","doi-asserted-by":"publisher","award":["Eugene Cota-Robles"],"award-info":[{"award-number":["Eugene Cota-Robles"]}],"id":[{"id":"10.13039\/100014576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006293","name":"American Society of Clinical Oncology","doi-asserted-by":"publisher","award":["Conquer Cancer Foundation of ASCO Career Development Award"],"award-info":[{"award-number":["Conquer Cancer Foundation of ASCO Career Development Award"]}],"id":[{"id":"10.13039\/100006293","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009730","name":"Stand Up To Cancer","doi-asserted-by":"publisher","award":["SU2C-AACR-DT22-17"],"award-info":[{"award-number":["SU2C-AACR-DT22-17"]}],"id":[{"id":"10.13039\/100009730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R00CA197762"],"award-info":[{"award-number":["R00CA197762"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA015704"],"award-info":[{"award-number":["P30 CA015704"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DGE-1258485"],"award-info":[{"award-number":["DGE-1258485"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","award":["Dale F. Frey Award"],"award-info":[{"award-number":["Dale F. Frey Award"]}],"id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    While advancements in genome sequencing have identified millions of somatic mutations in cancer, their functional impact is poorly understood. We previously developed the expression-based variant impact phenotyping (eVIP) method to use gene expression data to characterize the function of gene variants. The eVIP method uses a decision tree-based algorithm to predict the functional impact of somatic variants by comparing gene expression signatures induced by introduction of wild-type (WT) versus mutant cDNAs in cell lines. The method distinguishes between variants that are gain-of-function, loss-of-function, change-of-function, or neutral. We present eVIP2, software that allows for pathway analysis (eVIP Pathways) and usage with RNA-seq data. To demonstrate the eVIP2 software and approach, we characterized two recurrent frameshift variants in RNF43, a negative regulator of Wnt signaling, frequently mutated in colorectal, gastric, and endometrial cancer. RNF43 WT, RNF43 R117fs, RNF43 G659fs, or GFP control cDNA were overexpressed in HEK293T cells. Analysis with eVIP2 predicted that the frameshift at position 117 was a loss-of-function mutation, as expected. The second frameshift at position 659 has been previously described as a passenger mutation that maintains the RNF43 WT function as a negative regulator of Wnt. Surprisingly, eVIP2 predicted G659fs to be a change-of-function mutation. Additional eVIP Pathways analysis of RNF43 G659fs predicted 10 pathways to be significantly altered, including TNF-\u03b1 via NF\u03baB signaling, KRAS signaling, and hypoxia, highlighting the benefit of a more comprehensive approach when determining the impact of gene variant function. To validate these predictions, we performed reporter assays and found that each pathway activated by expression of RNF43 G659fs, but not expression of RNF43 WT, was identified as impacted by eVIP2, supporting that RNF43 G659fs is a change-of-function mutation and its effect on the identified pathways. Pathway activation was further validated by Western blot analysis. Lastly, we show primary colon adenocarcinoma patient samples with R117fs and G659fs variants have transcriptional profiles similar to BRAF missense mutations with activated RAS\/MAPK signaling, consistent with KRAS signaling pathways being GOF in both variants. The eVIP2 method is an important step towards overcoming the current challenge of variant interpretation in the implementation of precision medicine. eVIP2 is available at\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/github.com\/BrooksLabUCSC\/eVIP2\" xlink:type=\"simple\">https:\/\/github.com\/BrooksLabUCSC\/eVIP2<\/jats:ext-link>\n                    .\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1009132","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T14:29:45Z","timestamp":1625236185000},"page":"e1009132","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7987-2543","authenticated-orcid":true,"given":"Alexis M.","family":"Thornton","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0183-861X","authenticated-orcid":true,"given":"Lishan","family":"Fang","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6128-9846","authenticated-orcid":true,"given":"April","family":"Lo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-5441","authenticated-orcid":true,"given":"Maria","family":"McSharry","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6842-1010","authenticated-orcid":true,"given":"David","family":"Haan","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6572-4881","authenticated-orcid":true,"given":"Casey","family":"O\u2019Brien","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6538-2658","authenticated-orcid":true,"given":"Alice H.","family":"Berger","sequence":"additional","affiliation":[]},{"given":"Marios","family":"Giannakis","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7898-3073","authenticated-orcid":true,"given":"Angela N.","family":"Brooks","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"pcbi.1009132.ref001","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrc1299","article-title":"A census of human cancer genes","author":"PA Futreal","year":"2004","journal-title":"Nature Reviews Cancer"},{"key":"pcbi.1009132.ref002","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","author":"Network TCGAR, The Cancer Genome Atlas Research Network","year":"2008","journal-title":"Nature"},{"key":"pcbi.1009132.ref003","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature08987","article-title":"International network of cancer genome projects","volume":"464","author":"International Cancer Genome Consortium","year":"2010","journal-title":"Nature"},{"key":"pcbi.1009132.ref004","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium","year":"2020","journal-title":"Nature"},{"key":"pcbi.1009132.ref005","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"J Lamb","year":"2006","journal-title":"Science"},{"key":"pcbi.1009132.ref006","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1158\/2159-8290.CD-16-0160","article-title":"Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles","volume":"6","author":"E Kim","year":"2016","journal-title":"Cancer Discov"},{"key":"pcbi.1009132.ref007","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ccell.2017.11.008","article-title":"High-throughput Phenotyping of Lung Cancer Somatic Mutations","volume":"32","author":"AH Berger","year":"2017","journal-title":"Cancer Cell"},{"key":"pcbi.1009132.ref008","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles","volume":"171","author":"A Subramanian","year":"2017","journal-title":"Cell"},{"key":"pcbi.1009132.ref009","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","article-title":"Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences.","volume":"4","author":"C Soneson","year":"2015","journal-title":"F1000Res"},{"key":"pcbi.1009132.ref010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal RNA-Seq quantification with kallisto","volume":"34","author":"N Bray","year":"2016","journal-title":"Nat Biotechnol"},{"key":"pcbi.1009132.ref011","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1261\/rna.053959.115","article-title":"How many biological replicates are needed in an RNA-seq experiment and which differential expression tool should you use?","volume":"22","author":"NJ Schurch","year":"2016","journal-title":"RNA"},{"key":"pcbi.1009132.ref012","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"A Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"pcbi.1009132.ref013","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"M Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1009132.ref014","doi-asserted-by":"crossref","first-page":"D472","DOI":"10.1093\/nar\/gkt1102","article-title":"The Reactome pathway knowledgebase","volume":"42","author":"D Croft","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1009132.ref015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"MI Love","year":"2014","journal-title":"Genome Biol"},{"key":"pcbi.1009132.ref016","doi-asserted-by":"crossref","first-page":"e60788","DOI":"10.1371\/journal.pone.0060788","article-title":"Characterization of FUS mutations in amyotrophic lateral sclerosis using RNA-Seq","volume":"8","author":"M van Blitterswijk","year":"2013","journal-title":"PLoS One"},{"key":"pcbi.1009132.ref017","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ajhg.2016.11.012","article-title":"Mutations in EBF3 Disturb Transcriptional Profiles and Cause Intellectual Disability, Ataxia, and Facial Dysmorphism","author":"FL Harms","year":"2017","journal-title":"The American Journal of Human Genetics"},{"key":"pcbi.1009132.ref018","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1476-4598-7-92","article-title":"Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context","volume":"7","author":"M Monticone","year":"2008","journal-title":"Mol Cancer."},{"key":"pcbi.1009132.ref019","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/sj.bjc.6604882","article-title":"Overexpressed vs mutated Kras in murine fibroblasts: a molecular phenotyping study","volume":"100","author":"M Horsch","year":"2009","journal-title":"Br J Cancer"},{"key":"pcbi.1009132.ref020","doi-asserted-by":"crossref","first-page":"e0160519","DOI":"10.1371\/journal.pone.0160519","article-title":"Lollipops in the Clinic: Information Dense Mutation Plots for Precision Medicine","volume":"11","author":"JJ Jay","year":"2016","journal-title":"PLoS One."},{"key":"pcbi.1009132.ref021","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nat Genet"},{"key":"pcbi.1009132.ref022","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.celrep.2016.10.009","article-title":"Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma","volume":"17","author":"M Giannakis","year":"2016","journal-title":"Cell Rep"},{"key":"pcbi.1009132.ref023","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature11019","article-title":"ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner","volume":"485","author":"H-X Hao","year":"2012","journal-title":"Nature"},{"key":"pcbi.1009132.ref024","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nature11308","article-title":"Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors","volume":"488","author":"B-K Koo","year":"2012","journal-title":"Nature"},{"key":"pcbi.1009132.ref025","doi-asserted-by":"crossref","first-page":"ra90","DOI":"10.1126\/scisignal.aac6757","article-title":"The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated \u03b2-catenin by sequestering TCF4 to the nuclear membrane","volume":"8","author":"A Loregger","year":"2015","journal-title":"Sci Signal."},{"key":"pcbi.1009132.ref026","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ng.3127","article-title":"RNF43 is frequently mutated in colorectal and endometrial cancers","volume":"46","author":"M Giannakis","year":"2014","journal-title":"Nat Genet"},{"key":"pcbi.1009132.ref027","article-title":"Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy","author":"M Angelova","year":"2015","journal-title":"Genome Biology"},{"key":"pcbi.1009132.ref028","first-page":"1853","article-title":"RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer","volume":"43","author":"A Matsumoto","year":"2020","journal-title":"Oncol Rep"},{"key":"pcbi.1009132.ref029","first-page":"711382","article-title":"The most common RNF43 mutant G659Vfs41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis","author":"J Tu","year":"2019","journal-title":"bioRxiv"},{"key":"pcbi.1009132.ref030","first-page":"1","article-title":"The most common RNF43 mutant G659Vfs* 41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis","volume":"9","author":"J Tu","year":"2019","journal-title":"Sci Rep"},{"key":"pcbi.1009132.ref031","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1109\/TVCG.2014.2346248","article-title":"UpSet: Visualization of Intersecting Sets","volume":"20","author":"A Lex","year":"2014","journal-title":"IEEE Trans Vis Comput Graph"},{"key":"pcbi.1009132.ref032","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pcbi.1009132.ref033","doi-asserted-by":"crossref","first-page":"956","DOI":"10.17586\/2226-1494-2016-16-5-956-959","article-title":"Algorithm for cumulative calculation of gene set enrichment statistic","author":"AA Sergushichev","year":"2016","journal-title":"Scientific and Technical Journal of Information Technologies, Mechanics and Optics."},{"key":"pcbi.1009132.ref034","first-page":"060012","author":"G Korotkevich","year":"2019","journal-title":"Fast gene set enrichment analysis"},{"key":"pcbi.1009132.ref035","article-title":"Using Transcriptional Signatures to Find Cancer Drivers with LURE","author":"D Haan","year":"2019","journal-title":"Biocomputing"},{"key":"pcbi.1009132.ref036","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41698-018-0051-4","article-title":"A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types","volume":"2","author":"M-C Wagle","year":"2018","journal-title":"NPJ Precis Oncol"},{"key":"pcbi.1009132.ref037","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic Signaling Pathways in The Cancer Genome Atlas","volume":"173","author":"F Sanchez-Vega","year":"2018","journal-title":"Cell"},{"key":"pcbi.1009132.ref038","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3892\/or.2014.2970","article-title":"TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-\u03b21","volume":"31","author":"YH Kim","year":"2014","journal-title":"Oncol Rep"},{"key":"pcbi.1009132.ref039","first-page":"2017","article-title":"OncoKB: A Precision Oncology Knowledge Base","author":"D Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"pcbi.1009132.ref040","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.2011.39.5814","article-title":"Identification of a Poor-Prognosis BRAF-Mutant\u2013Like Population of Patients With Colon Cancer","author":"V Popovici","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"pcbi.1009132.ref041","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/gutjnl-2012-302423","article-title":"A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction","volume":"62","author":"S Tian","year":"2013","journal-title":"Gut"},{"key":"pcbi.1009132.ref042","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1158\/0008-5472.CAN-16-2821","article-title":"Oncogenic Effects of High MAPK Activity in Colorectal Cancer Mark Progenitor Cells and Persist Irrespective of RAS Mutations","volume":"77","author":"C Blaj","year":"2017","journal-title":"Cancer Res"},{"key":"pcbi.1009132.ref043","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12079-017-0441-3","article-title":"Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer","volume":"12","author":"K Tripathi","year":"2018","journal-title":"J Cell Commun Signal"},{"key":"pcbi.1009132.ref044","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.18632\/oncotarget.6818","article-title":"Oncogenic KRAS activates an embryonic stem cell-like program in human colon cancer initiation","volume":"7","author":"A-F Le Rolle","year":"2016","journal-title":"Oncotarget"},{"key":"pcbi.1009132.ref045","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1038\/onc.2010.218","article-title":"Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells","volume":"29","author":"Y Wang","year":"2010","journal-title":"Oncogene"},{"key":"pcbi.1009132.ref046","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.18632\/oncotarget.23645","article-title":"Kanglaite inhibits EMT caused by TNF-\u03b1 via NF-\u03ba\u0392 inhibition in colorectal cancer cells","volume":"9","author":"G Shi","year":"2018","journal-title":"Oncotarget"},{"key":"pcbi.1009132.ref047","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1038\/sj.onc.1210546","article-title":"Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition","volume":"26","author":"S Julien","year":"2007","journal-title":"Oncogene"},{"key":"pcbi.1009132.ref048","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.yexcr.2016.10.005","article-title":"Claudin-1 promotes TNF-\u03b1-induced epithelial-mesenchymal transition and migration in colorectal adenocarcinoma cells","volume":"349","author":"AA Bhat","year":"2016","journal-title":"Exp Cell Res"},{"key":"pcbi.1009132.ref049","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1091\/mbc.e02-09-0583","article-title":"Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids","volume":"14","author":"RC Bates","year":"2003","journal-title":"Mol Biol Cell"},{"key":"pcbi.1009132.ref050","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines5020021","article-title":"Hypoxia and Inflammation in Cancer, Focus on HIF and NF-\u03baB.","volume":"5","author":"L D\u2019Ignazio","year":"2017","journal-title":"Biomedicines"},{"key":"pcbi.1009132.ref051","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"JT Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"key":"pcbi.1009132.ref052","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"E Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"pcbi.1009132.ref053","first-page":"l1","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"J Gao","year":"2013","journal-title":"Sci Signal"},{"key":"pcbi.1009132.ref054","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.cell.2013.10.011","article-title":"Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome","volume":"155","author":"T Davoli","year":"2013","journal-title":"Cell"},{"key":"pcbi.1009132.ref055","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.2591","article-title":"Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity","volume":"45","author":"AM Dulak","year":"2013","journal-title":"Nat Genet"},{"key":"pcbi.1009132.ref056","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/2159-8290.CD-14-0623","article-title":"Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma","volume":"4","author":"EM Van Allen","year":"2014","journal-title":"Cancer Discov"},{"key":"pcbi.1009132.ref057","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","article-title":"The long tail of oncogenic drivers in prostate cancer","volume":"50","author":"J Armenia","year":"2018","journal-title":"Nat Genet"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1009132","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T10:12:40Z","timestamp":1672654360000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009132"}},"subtitle":[],"editor":[{"given":"Mihaela","family":"Pertea","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1009132","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/872028","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]}}}